Our Pipeline
Key Trials
We focus on advancing CAR-T therapies designed to harness the immune system against blood cancers.
Next Steps
Our upcoming studies aim to expand indications and improve safety profiles for broader patient impact.
Research Gallery
Snapshots capturing Celyad Oncology’s pioneering biotech work.
